Table 2.
Characteristics of AKI cohort
| Characteristics | Control group | AKI group |
||
|---|---|---|---|---|
| 1 | 2 | 3 | ||
| n | 15 | 35 | 13 | 15 |
| Age, yr | ||||
| Mean | 58.5 | 70.3 | 68.9 | 65.8 |
| SD | 19.0 | 11.9 | 15.7 | 11.4 |
| Range | 24–89 | 40–86 | 34–84 | 36–80 |
| Sex, n (%) | ||||
| Male | 7 (47%) | 26 (74%) | 10 (77%) | 7 (47%) |
| Female | 8 (53%) | 9 (26%) | 3 (23%) | 8 (53%) |
| Baseline SCr (mg/dl) | - | |||
| Mean | 0.94 | 0.91 | 0.68 | |
| SD | 0.20 | 0.23 | 0.22 | |
| Range | 0.55–1.38 | 0.53–1.42 | 0.33–1.31 | |
| SCr on day of measurement (mg/dl) | - | |||
| Mean | 1.30 | 1.67 | 2.53 | |
| SD | 0.29 | 0.56 | 1.93 | |
| Range | 0.78–2.02 | 0.53–2.62 | 0.75–7.72 | |
| Etiology of AKI, n (%) | - | |||
| Cardiac event | 16 (46%) | 2 (15%) | 4 (27%) | |
| Septic | 2 (6%) | 6 (46%) | 7 (46%) | |
| Multifactorial | 17 (48%) | 5 (38%) | 4 (27%) | |
| Chronic kidney disease, n (%) | - | |||
| Yes | 10 (29%) | 2 (15%) | 1 (7%) | |
| No | 25 (71%) | 11 (85%) | 14 (93%) | |
| MAKE-30 | - | |||
| Yes | 6 (17%) | 3 (23%) | 7 (47%) | |
| No | 29 (83%) | 10 (77%) | 8 (53%) | |
AKI, acute kidney injury; KDIGO, Kidney Disease: Improving Global Outcomes; MAKE-30, major adverse kidney events within 30 days of AKI onset.; SCr, serum creatinine.
Values are mean (range).